Gene Therapy
A plain-English guide to gene therapy in rare disease: what the platform is trying to solve, why families are watching it closely, and how it connects to interviews, explainers, trials, and care decisions.
Hub
Gene therapy, RNA medicine, newborn genome sequencing, and the treatment platforms changing the future of rare disease.
Each topic can connect to explainers, interviews, news updates, and future CMS entries.
A plain-English guide to gene therapy in rare disease: what the platform is trying to solve, why families are watching it closely, and how it connects to interviews, explainers, trials, and care decisions.
A plain-English guide to rna therapy in rare disease: what the platform is trying to solve, why families are watching it closely, and how it connects to interviews, explainers, trials, and care decisions.
A plain-English guide to aso therapy in rare disease: what the platform is trying to solve, why families are watching it closely, and how it connects to interviews, explainers, trials, and care decisions.
A plain-English guide to exon skipping in rare disease: what the platform is trying to solve, why families are watching it closely, and how it connects to interviews, explainers, trials, and care decisions.
A plain-English guide to base editing in rare disease: what the platform is trying to solve, why families are watching it closely, and how it connects to interviews, explainers, trials, and care decisions.
A plain-English guide to prime editing in rare disease: what the platform is trying to solve, why families are watching it closely, and how it connects to interviews, explainers, trials, and care decisions.
A plain-English guide to cell therapy in rare disease: what the platform is trying to solve, why families are watching it closely, and how it connects to interviews, explainers, trials, and care decisions.
A plain-English guide to newborn genome sequencing in rare disease: what the platform is trying to solve, why families are watching it closely, and how it connects to interviews, explainers, trials, and care decisions.
A plain-English guide to clinical trials in rare disease: what the platform is trying to solve, why families are watching it closely, and how it connects to interviews, explainers, trials, and care decisions.
Dr. Guoping Feng
Welcome — I’m Ron Kleiman, and this is GENEration Hope. In this episode, I’m joined by Dr. Guoping Feng, Professor of Neuroscience at MIT, affiliated with the McGovern Institute, the Yang Tan Collective, and the Broad Institute. 
Watch InterviewSue Lomas
Sue Lomas helped build the Phelan-McDermid Syndrome community in the earliest days—when families were scattered, information was scarce, and finding “your people” took persistence. In this conversation, Sue and I talk about how rare-dise...
Watch Interview
Gene therapy is a treatment approach that tries to address disease at the level of the gene, often by adding, replacing, silencing, or editing genetic instructions.

ASO therapy uses short pieces of synthetic genetic material to change how RNA is read, processed, or reduced inside cells.